fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Could semaglutide prevent cardiometabolic disease?

Written by | 12 May 2023

Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial… read more.

Do I need semaglutide and how can I get it?

Written by | 11 May 2023

Semaglutide works well on its own as obesity treatment but it works even better with the support and guidance of a multi-disciplinary weight-management team, according to Alex Miras,… read more.

NICE recommends semaglutide for obesity

Written by | 10 May 2023

In March 2023 the National Institute for Health and Care Excellence (NICE) published Technology Appraisal Guidance for semaglutide for obesity. Professor Alex Miras explains the guidance and its… read more.

Semaglutide – a game-changer in obesity management

Written by | 9 May 2023

Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for… read more.

Deprescribing to optimise drug therapy

Written by | 27 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

CHARMER – a different kind of deprescribing intervention study

Written by | 26 Apr 2023

The CHARMER study of a proactive deprescribing intervention is different from previous studies and addresses five critical factors identified by prescribers and patients as being key to success,… read more.

Barriers and enablers for deprescribing

Written by | 25 Apr 2023

There is no ‘one-size-fits-all’ deprescribing intervention and a good understanding of the barriers and enablers to effective deprescribing is needed, according to Debi Bhattacharya, Professor of Behavioural Medicine… read more.

Deprescribing – reactive and proactive

Written by | 24 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

NICE Quality Standards for managing chronic heart failure

Written by | 10 Mar 2023

Dr Rani Khatib is a Consultant Cardiology Pharmacist at Leeds Teaching Hospitals NHS Trust and Associate Professor at the Leeds Institute for Cardiometabolic Medicine (LICaM), University of Leeds. As… read more.

What are the implications of the NICE Quality Standards?

Written by | 9 Mar 2023

The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr… read more.

Why do we need NICE Quality Standards for chronic heart failure?

Written by | 8 Mar 2023

Dr Rani Khatib is a consultant pharmacist in cardiology and cardiovascular research and associate professor at the University of Leeds. As a member of the NICE Guideline Development… read more.

Hospital Pharmacy services in the aftermath of Hurricane Ian

Written by | 17 Feb 2023

John A. Armitstead is the System Director of Pharmacy at Lee Health in Fort Myers, Florida. During the past five years, Fort Myers has twice been hit by… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.